JPMORGAN CHASE & CO - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 52 filers reported holding FINCH THERAPEUTICS GROUP INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2022$18,000
-62.5%
3,550
-26.3%
0.00%
Q4 2021$48,000
-20.0%
4,820
+4.4%
0.00%
Q3 2021$60,000
-57.4%
4,618
-53.9%
0.00%
Q2 2021$141,00010,0210.00%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q4 2021
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$653,7033.23%
Bleichroeder LP 810,416$318,4930.07%
Ikarian Capital, LLC 237,553$93,3590.02%
LAKE STREET ADVISORS GROUP, LLC 739,136$2910.02%
Baupost Group 2,019,008$7930.01%
Proficio Capital Partners LLC 110,559$43,4500.01%
MSD Partners, L.P. 153,397$60,2850.01%
Ballentine Partners, LLC 143,603$56,4360.00%
SVB WEALTH LLC 253,054$99,4500.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 18,783$7,3820.00%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders